Year: 2023

EyeBio_Logo

EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoretâ„¢ in Neovascular Age Related Macular Degeneration and Diabetic Macular Edema

- AMARONE (Anti-permeability Mechanism and Age-Related Ocular Neovascularization Evaluation) is first clinical trial of EyeBio’s lead asset Restoret, a Wnt...

photo-1

First Edition of the Hang Lung Future Women Leaders Program Concludes with Students from the Mainland and Hong Kong Engaged in Exchange and Interaction to Co-create a Sustainable Future

Outstanding students will soon participate in internships to enhance their workplace competitiveness SHANGHAI, CHINA - Media OutReach - 14 June...

NEXT_Horiz_FullColor_Logo_-_Copy

NextDecade Announces Framework Agreements with Global Infrastructure Partners and TotalEnergies to Support the Development of the Rio Grande LNG Project

  HOUSTON--(BUSINESS WIRE)--NextDecade Corporation (NextDecade) (NASDAQ: NEXT) today announced that it has entered into framework agreements with Global Infrastructure Partners...